Globe Life Q3 2026 Earnings: Premium Growth Was Offset by Underwriting Pressure

Globe Life (NYSE: GL) reported Q3 2026 total revenue of $1.596 billion, up about 5% from $1.513 billion a year earlier, while diluted GAAP EPS declined to $4.62 from $4.73. Total premium revenue increased 7%, but non-GAAP insurance underwriting income fell 4% as lower life margins and losses at United American outweighed health premium growth. Non-GAAP operating EPS edged up 1% because the diluted share count declined.

Core Earnings Data

Revenue growth was driven by a 7% increase in insurance premiums and a 3% rise in net investment income. However, total policyholder benefits increased about 13%, outpacing revenue growth and contributing to lower pretax income and GAAP net income.

The annual reserve assumption update also affected year-over-year comparisons. Q3 2026 included a $120.5 million pretax remeasurement gain from assumption updates, compared with $134.3 million in Q3 2025.

Business and Segment Performance

Life insurance generated 66% of premium revenue and 80% of insurance underwriting margin. Life premiums rose 2%, but life underwriting margin declined 5%, with the margin rate falling to 53% of premium from 57%.

Health premiums increased 16% and health net sales rose 32%. Health underwriting margin grew more slowly at 7%, however, and its margin rate declined to 26% from 28%.

United American was the primary source of health premium and sales growth, with premiums up 29% and net sales up 95%. That growth did not translate into underwriting profit: the division recorded a $6.4 million health underwriting loss, compared with a $16.1 million margin a year earlier. Globe Life attributed the result mainly to an approximately $16 million underwriting loss at Evry and roughly $7 million of excess prior-period Medicare Supplement claims caused by a Centers for Medicare and Medicaid Services processing delay.

Family Heritage delivered a more balanced result, with health premiums up 8%, net sales up 5%, and underwriting margin up 12%. American Income’s reported health underwriting margin increased 155%, although annual assumption updates significantly affected the comparison.

Within life insurance, American Income premiums rose 4% while net sales were flat and its average producing agent count declined 7%. Liberty National increased life premiums 4% and net sales 7%, supported by a 9% increase in producing agents. Direct to Consumer life net sales fell 12% and premiums declined 1%.

Profitability, Investments, and Capital

The ratio of administrative expenses to premiums remained unchanged at 7.3%, indicating that the decline in underwriting income was not caused by deterioration in that expense ratio. The larger pressures came from life underwriting margins and the United American health losses.

Excess investment income increased 3% to $37.9 million, while excess investment income per diluted share rose 9% to $0.49. Net investment income and average invested assets each grew 3%, compared with 4% growth in required interest and average policy liabilities.

At September 30, 2026, Globe Life’s investment portfolio had a book value of $19.63 billion. Fixed maturities represented 86% of the total portfolio, and 97% of fixed maturities were investment grade. The fixed-maturity portfolio’s taxable-equivalent effective yield increased to 5.33% from 5.26%.

Fixed maturities had a fair value of $16.87 billion and net amortized cost of $19.56 billion, resulting in $2.69 billion of net unrealized losses recorded in accumulated other comprehensive income. Book value per share increased 23% to $85.35, while book value excluding AOCI rose 11% to $103.62.

A Lower Share Count Supported Operating EPS

Globe Life’s non-GAAP operating income declined 4% in dollar terms, but operating income per diluted share increased 1%. Weighted average diluted shares fell to 78.2 million from 82.0 million, a reduction of about 5%, which offset the decline in operating profit on a per-share basis.

The company repurchased 1.1 million shares during the quarter for $185 million at an average price of $175.61. The lower share count was not enough to prevent GAAP EPS from declining, as GAAP net income fell by about 7%.

Earnings Guidance

Globe Life adjusted its full-year 2026 earnings guidance to $15.35 to $15.65. Management attributed the adjustment to Evry’s high-severity claims and the CMS processing delay rather than a fundamental change in the underlying core business.

The company also introduced 2027 net operating income guidance and raised its expected 2026 share-repurchase spending.

Recent Insider Transactions

The supplied six-month insider summary shows 383,835 shares purchased across 25 transactions and 357,540 shares sold across 23 transactions, resulting in net purchases of 26,295 shares. The 10 most recently reported records consist of sales and derivative-security conversions, all involving direct ownership.

Risks Investors Need to Watch

• United American claims volatility: Evry’s approximately $16 million underwriting loss and $7 million of excess Medicare Supplement claims turned United American’s health underwriting margin negative despite substantial premium and sales growth.
• Reserve assumption effects: Annual assumption updates produced a smaller pretax remeasurement gain than in the prior-year quarter. Future assumption and experience adjustments can continue to affect reported underwriting margins and earnings comparisons.
• Uneven distribution trends: American Income’s producing agent count declined 7%, while Direct to Consumer life net sales fell 12%. Continued weakness in these areas could limit future life premium growth.
• Investment spread and balance-sheet sensitivity: Required interest on policy liabilities grew faster than net investment income during the quarter, while the fixed-maturity portfolio carried $2.69 billion of net unrealized losses that affected GAAP equity and book value.

Summary

Globe Life’s Q3 2026 premium growth was concentrated in health insurance, but the United American losses and lower life underwriting margins prevented that growth from translating into higher underwriting profit. Repurchases and a lower diluted share count supported non-GAAP operating EPS, while GAAP EPS declined. The main issues to monitor are whether United American converts rapid premium and sales growth into stable underwriting results, how reserve updates affect future comparisons, and whether life distribution trends improve.